Medpace officer Stephen P. Ewald proposes $859K sale

The securities information lists 27,971,686 shares outstanding, separate from the 1,245 shares proposed for sale.

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) officer Stephen P. Ewald reported a proposed sale of 1,245 common shares, with an aggregate market value of $859,050.00 and an approximate sale date of October 29, 2026. Fidelity Brokerage Services LLC is named as broker. The shares were acquired from the issuer through a stock option exercise on October 27, 2025. Wade Moss signed as a duly authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Ewald.

Key Figures

Common shares proposed for sale: 1,245 shares Aggregate market value: $859,050.00 Shares outstanding: 27,971,686 shares +2 more

5 metrics

Common shares proposed for sale 1,245 shares Proposed sale

Aggregate market value $859,050.00 Proposed sale

Shares outstanding 27,971,686 shares Figure listed in the securities information

Approximate sale date October 29, 2026 Proposed sale

Acquisition date October 27, 2025 Stock option exercise

Key Terms

aggregate market value, Stock Option Exercise, Rule 144

3 terms

aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Stock Option Exercise financial

"Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Rule 144 regulatory

"definition of person in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MEDP shares did Stephen P. Ewald report for sale?

Stephen P. Ewald, an officer of Medpace, reported a proposed sale of 1,245 common shares with an aggregate market value of $859,050.00. Fidelity Brokerage Services LLC is named as broker, and October 29, 2026, is the approximate sale date.

How did Stephen P. Ewald acquire the MEDP shares proposed for sale?

The notice says the 1,245 common shares were acquired from the issuer through a stock option exercise on October 27, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/29/2026 - 03:37 PM EDT Accepted by SEC EDGAR 10/29/2026 - 03:36 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001677297
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medpace Holdings, Inc.
SEC File Number	001-37856
Address of Issuer	5375 MEDPACE WAY CINCINNATI OHIO 45227
Phone	(513) 579-9911
Name of Person for Whose Account the Securities are To Be Sold	EWALD STEPHEN P
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1245	859050.00	27971686	10/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/27/2025	Stock Option Exercise	Issuer			1245	10/27/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/29/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Stephen P. Ewald
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)